Bayesian Cure Rate Modeling of Local Tumor Control: Evaluation in Stereotactic Body Radiation Therapy for Pulmonary Metastases.

[1]  James E. Helmreich.  Regression Modeling Strategies with Applications to Linear Models, Logistic and Ordinal Regression and Survival Analysis (2nd Edition) , 2016 .

[2]  Oliver Blanck,et al.  Local tumor control probability modeling of primary and secondary lung tumors in stereotactic body radiotherapy. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[3]  P. Iyengar,et al.  Phase II trial of stereotactic body radiation therapy combined with erlotinib for patients with limited but progressive metastatic non-small-cell lung cancer. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  Leonid Hanin,et al.  Identifiability of cure models revisited , 2014, J. Multivar. Anal..

[5]  M. Duma,et al.  SBRT for Lung Metastases: A Pooled Analysis of 651 Patients and 868 Lesions of the German Working Group Stereotactic Radiotherapy , 2014 .

[6]  Matthias Guckenberger,et al.  Applicability of the linear-quadratic formalism for modeling local tumor control probability in high dose per fraction stereotactic body radiotherapy for early stage non-small cell lung cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[7]  P. Bunn,et al.  Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer , 2012, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[8]  P. Okunieff,et al.  Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study. , 2012, International journal of radiation oncology, biology, physics.

[9]  Stef van Buuren,et al.  MICE: Multivariate Imputation by Chained Equations in R , 2011 .

[10]  F. Esposito,et al.  Adaptation to oxidative stress, chemoresistance, and cell survival. , 2009, Antioxidants & redox signaling.

[11]  Radhe Mohan,et al.  Analysis of radiation pneumonitis risk using a generalized Lyman model. , 2008, International journal of radiation oncology, biology, physics.

[12]  A. Gelman.  Scaling regression inputs by dividing by two standard deviations , 2008, Statistics in medicine.

[13]  Bradley P Carlin,et al.  Flexible Cure Rate Modeling Under Latent Activation Schemes , 2007, Journal of the American Statistical Association.

[14]  Brian Keith,et al.  Hypoxia-Inducible Factors, Stem Cells, and Cancer , 2007, Cell.

[15]  Joseph G. Ibrahim,et al.  Bayesian Survival Analysis , 2004 .

[16]  Joseph G. Ibrahim,et al.  Bayesian cure rate models for malignant melanoma: a case‐study of Eastern Cooperative Oncology Group trial E1690 , 2002 .

[17]  Chin-Shang Li,et al.  Identifiability of cure models , 2001 .

[18]  Frank E. Harrell,et al.  Regression Modeling Strategies: With Applications to Linear Models, Logistic Regression, and Survival Analysis , 2001 .

[19]  Joseph G. Ibrahim,et al.  A New Bayesian Model For Survival Data With a Surviving Fraction , 1999 .

[20]  B. Asselain,et al.  A PARAMETRIC ANALYSIS OF TUMOR RECURRENCE DATA , 1996 .

[21]  H. Thames,et al.  How well is the probability of tumor cure after fractionated irradiation described by Poisson statistics? , 1990, Radiation research.

[22]  H. Thames,et al.  Latent-time estimation for late cutaneous and subcutaneous radiation reactions in a single-follow-up clinical study. , 1989, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[23]  H. Thames,et al.  Effect of latency on calculated complication rates. , 1986, International journal of radiation oncology, biology, physics.

[24]  V. Farewell.  A model for a binary variable with time-censored observations , 1977 .

[25]  Joseph Berkson,et al.  Survival Curve for Cancer Patients Following Treatment , 1952 .

[26]  Thomas Krieger,et al.  Influence of calculation model on dose distribution in stereotactic radiotherapy for pulmonary targets. , 2005, International journal of radiation oncology, biology, physics.

[27]  J M Taylor,et al.  Statistical models for analysing time-to-occurrence data in radiobiology and radiation oncology. , 1993, International journal of radiation biology.

[28]  H D Thames,et al.  Direct estimation of latent time for radiation injury in late-responding normal tissues: gut, lung, and spinal cord. , 1989, International journal of radiation biology.

[29]  H. Withers,et al.  Fitting the linear-quadratic model using time of occurrence as the end-point for quantal response multifraction experiments. , 1987, International journal of radiation biology and related studies in physics, chemistry, and medicine.